News

Professor Janet Davies article explains how to prepare for thunderstorm asthma this season

high Pollen

In a recent article in The Conversation, CIIC Researcher Professor Janet Davies, explains how people can prepare for the high possibility of thunderstorm asthma, in South Eastern Australia this season. Thunderstorm asthma occurs when levels of grass pollen in the air are high and when thunderstorms pass over high pollen sources. Read…

CIIC HDR Symposium

The 2023 CIIC HDR symposium will be held on Wednesday 8 November, 11am – 2.15pm at QIMR Berghofer, providing a valuable opportunity for CIIC HDR students to showcase their research. If you would like to attend please contact ciic-enquiries@qut.edu.au…

CIIC Research Symposium and Partner Networking Event

CIIC will be hosting the 2023 Research Symposium and Partner Networking event on Wednesday 8 November. This event will provide an opportunity to celebrate research excellence, collaboration, and network with colleagues. We are delighted to welcome Queensland Chief Health Officer Dr John Gerrard to deliver the keynote presentation: “The…

Chlamydia booster vaccine shot using implant technology for koalas under development

Prof Ken Beagley

Professor Ken Beagley, from the Centre for Immunology and Infection Control is leading a research team to develop a booster vaccine using implant technology for koalas in the fight against the deadly Chlamydia disease, after being awarded a health grant to develop the technology from the Saving Koalas Fund. The new technology is designed…

CIIC success at ASM national meeting 2023

Johanna Kenyon Frank Fenner recipient

CIIC was well represented and enjoyed recent success at the ASM (Australian Society for Microbiology) national meeting in Perth last week. HDR student Sophia Hawas won a student poster award for her research Local germinal centre B cell activity in acute UTI in mice. Dr Johanna Kenyon was awarded the Frank Fenner Mid-Career Excellence…

Australian Universities collaboration leads to the launch of Resseptor Therapeutics to tackle inflammatory diseases

Image of Dr Stephen Daley

Dr Steve Daley, expert immunologist with QUT’s Centre for Immunology and Infection Control is the co-founding scientist at Resseptor Therapeutics, a new Australian biotech company which has launched with an initial AU$2.25 million investment to develop new therapies targeting autoimmune diseases and cancer. Resseptor aims to develop new…

Queensland allergy expert welcomes next gen pollen monitoring

Queenslanders’ with hayfever and asthma are set to benefit from the first high-precision, automated, pollen -monitoring instrument in the southern hemisphere, and its first use in a subtropical region. Professor Janet Davies, National Allergy Centre of Excellence (NACE) Respiratory and Discovery Hub Lead and QUT (Queensland University